NPI: 1235504101 · JERSEY CITY, NJ 07306 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 12/03/2015
Authorized official WINSTEL, JOHN controls 20+ related entities in our dataset. Read more
| Authorized Official | WINSTEL, JOHN (CHIEF ACCOUNTING OFFICER) |
| NPI Enumeration Date | 12/03/2015 |
Other providers sharing the same authorized official: WINSTEL, JOHN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 2,701 | $341K |
| 2019 | 5,602 | $657K |
| 2020 | 6,729 | $468K |
| 2021 | 10,041 | $316K |
| 2022 | 16,806 | $322K |
| 2023 | 7,568 | $196K |
| 2024 | 5,889 | $158K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 34,189 | 2,284 | $2.00M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 12,070 | 720 | $343K |
| A4657 | Syringe, with or without needle, each | 3,440 | 1,045 | $30K |
| 85041 | 801 | 602 | $16K | |
| 85048 | 767 | 579 | $16K | |
| J1270 | Injection, doxercalciferol, 1 mcg | 140 | 12 | $13K |
| 83970 | 409 | 265 | $9K | |
| 82728 | 375 | 255 | $6K | |
| J1756 | Injection, iron sucrose, 1 mg | 1,622 | 283 | $6K |
| 82108 | 153 | 132 | $5K | |
| 83540 | 462 | 310 | $5K | |
| 83550 | 344 | 252 | $5K | |
| G0008 | Administration of influenza virus vaccine | 149 | 98 | $688.52 |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 316 | 110 | $182.41 |
| 90674 | 45 | 17 | $1.53 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 18 | 14 | $0.00 |
| 90662 | 36 | 26 | $0.00 |